Submission Form

Top 4 facts life science companies need to know about the UPC

Top 4 facts life science companies need to know about the UPC

The UPC has been a long-awaited project and it will represent the biggest change in recent patent history. What will be the real commercial impact of the UPC? What can pharmaceutical and biotechnological companies do to prepare now? Ahead of the inaugural Life Sciences IP Summit (28th - 29th November 2017), we asked Dr Matthias Zigann, Presiding Judge at the Munich Regional Court to explain the top four facts life science companies need to know regarding the implementation of the UPC treaty and the future of the European patent landscape.
Innovation - Technology & Intellectual Property

Innovation - Technology & Intellectual Property

The Innovation - Technology and Intellectual Property reports contains numerous market studies and features on best practices for day-to-day business, with exclusive rankings of top law firms and corporate companies, interviews with opinion makers and round-ups of the year. It also has company directories with detailed company profiles. Use these tools for competitive branding and position your company as one of the best international specialists among your clients and business partners. 

Life Science IP: Map of Europe

Life Science IP: Map of Europe

IP protection and enforcement is critical to securing business success and there are few industries where the impact of IP management is as dramatic as life science. Ahead of the Life Science IP Conference, we have put together this useful industry map which provides a high level overview of the latest industry developments affecting Life Science Intellectual Property in various European nations.